Nitto BioPharma, Inc. | San Diego, CA

Drug Delivery Solutions

Nitto BioPharma Inc. (NBPI) offers unique drug and siRNA delivery solutions by designing novel biodegradable delivery vehicles with the combined ability to target specific cells and efficiently deliver a therapeutic moiety to the cells. Over the past several years, NBPI research has resulted in both lipid- and polymer-based drug delivery platforms.

Back: Technology

Leadership in Drug Delivery

We offer unique solutions to drug delivery by designing novel biodegradable delivery vehicles with the combined ability to target specific cells and efficiently deliver a therapeutic moiety to the target cells. Our research over the past several years has resulted in both lipid and polymer - based delivery systems that have been used for plasmid-based gene therapy, oligonucleotide therapy, and cancer chemotherapy.

Lipid nanoparticles (LNPs) have the potential to deliver therapeutic oligonucleotides to target cells in vitro and in vivo. Nitto’s state-of-the-art lipid nanoparticle targets hepatic stellate cells and delivers anti-HSP47 siRNA and effectively shuts down its synthesis and reverses progression of the fibrosis disease.

Key features of our LNP delivery system are:

NBPI’s LNP delivery system can target tumors with high specificity and navigate into the tissue and specific cells.

Our delivery systems exhibit the following properties/benefits:

©NITTO DENKO CORPORATION. 2016 All rights reserved.